8-K: Predictive Oncology Rebrands to Axe Compute, Changes Ticker

Predictive Oncology Inc. announced a corporate name change to Axe Compute Inc. and a new NASDAQ ticker symbol, AGPU, effective December 11, 2025.

Summary

• Predictive Oncology Inc. has officially changed its corporate name to Axe Compute Inc.
• The name change is effective December 11, 2025.
• The company's common stock will begin trading on The Nasdaq Stock Market LLC under the new ticker symbol AGPU on or about December 12, 2025.
• The Board of Directors approved the name change and the adoption of the Third Amended and Restated Bylaws.
• No stockholder approval was required for the name change under Delaware law.
• The CUSIP number for the company's common stock will remain unchanged.
• Outstanding stock certificates for shares of the company are not affected by the name change and remain valid, requiring no exchange.

Sentiment

Score: 5

Explanation: This filing is purely administrative, detailing a corporate name and ticker symbol change. It provides no direct financial or operational performance data to influence sentiment positively or negatively, hence a neutral score. The change in name from 'Predictive Oncology' to 'Axe Compute' might imply a strategic shift, but the filing itself does not elaborate on the reasons or potential impact, preventing a higher or lower score based on business prospects.

Future Outlook

NA

Management Comments

• The Board of Directors of the Company approved the Name Change pursuant to Section 242 of the General Corporation Law of the State of Delaware.
• In connection with the Name Change, the Board approved and adopted the Third Amended and Restated Bylaws, also effective on December 11, 2025, to reflect the corporate name Axe Compute Inc. and to integrate prior amendments to the Company's bylaws.

Industry Context

A name change from 'Predictive Oncology' to 'Axe Compute' suggests a significant strategic pivot away from oncology-focused AI/data science towards a broader or different computing domain. This could involve a shift towards high-performance computing, data processing, or a new core business focus, potentially aligning with broader trends in diversified technology or AI infrastructure development.

Corporate Governance

Stakeholder Impact

• Shareholders: Will see the company trade under a new name and ticker symbol (AGPU) but their existing stock certificates and CUSIP number remain valid. The change in name might signal a strategic shift that could impact future investment thesis.
• Customers/Partners: May need to update records and understand the new corporate identity, potentially indicating a shift in service offerings or focus.
• Employees: Will operate under a new company name, potentially reflecting a new corporate culture or strategic direction.

Next Steps

• Common stock to begin trading on The Nasdaq Stock Market LLC under the new ticker symbol AGPU on or about December 12, 2025.

Key Dates

Recommendation

The filing details an administrative corporate name and ticker symbol change, which does not provide sufficient information to alter an investment thesis. While the name change from 'Predictive Oncology' to 'Axe Compute' suggests a potential strategic pivot, the filing lacks details on the rationale, new business focus, or financial implications. Investors should hold their position and await further disclosures regarding the company's strategic direction and operational plans under the new identity before making any buy or sell decisions.

Keywords

Predictive Oncology, Axe Compute, POAI, AGPU, Name Change, Corporate Rebranding, NASDAQ, Bylaws Amendment, Corporate Governance